Stemagen Acquires Patent Rights to Novel technique of Producing Uniparental Embryonic Stem Cells
Filed in archive Diagnostics, Methodologies and Instrumentation , Patents and Intellectual Property Rights , Stem Cells by ruth on March 08, 2007

.Exclusive rights to a patent for a novel technique in producing these uniparental embryonic stem cells have been acquired by Stemagen.
In this week's issue of Genes and Development, Dr. John McLaughlin and his team of researchers at the University of Pennsylvania described the successful transplantation of differentiated uniparental cells to rescue mice subjected to lethal doses of radiation.
In conjunction, Stemagen is partnering with the University of Pennsylvania to assess the viability of human uniparental cells in regenerative medicine.
Read the full report.
[article abstract]
Permalink: Stemagen Acquires Patent Rights to Novel technique of Producing Uniparental Embryonic Stem Cells
Tags:
stem cells embyronic stem cells regenerative medicine biotech stem+cells
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/57021







